Cytomegalovirus in Medical News
Navigation Links
Cytomegalovirus in Medical News
Viral Infection Might Trigger High Blood Pressure
... animal studies indicate. Mice infected with cytomegalovirus (CMV) were more likely to develop not only high ... a CMV vaccine. "It is virtually certain that cytomegalovirus infection makes at least some contribution to ... disease in people," Schleiss said. "Obviously, cytomegalovirus is not the whole picture. There are other issues, ...... drug with a unique mechanism of action against cytomegalovirus and a favorable clinical safety profile to date, ... to current anti-CMV therapies. About cytomegalovirus CMV is a member of the herpes virus group, ... drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma ...
Cell death from cytomegalovirus may bring new life to treatment of retinal disease
... likely the body's well-intended effort to stop cytomegalovirus retinitis. "We can try to infect certain cells ... looking at mechanisms of retinal damage during cytomegalovirus infection," Dr. Atherton said. Tools include a ... blood and semen, it's most typically latent. cytomegalovirus retinitis' last big resurrection came with the ...... Human cytomegalovirus Stimulates Telomerase Activity in Tissue Culture Cells Infection with human cytomegalovirus (HCMV) triggers expression of the telomerase reverse transcriptase (hTERT) ...
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
... changes in metabolic flux in human cells as they become infected by human cytomegalovirus (HCMV), an enveloped virus of the b-herpes family that infects most human ... severe disease in those with weakened immune systems. Researchers chose cytomegalovirus for experiments because it serves as an excellent model for processes at ...ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
... has granted orphan drug designation for CAMVIA for the prevention of cytomegalovirus (CMV) disease in patients with impaired cell-mediated immunity. The ... of CMV that are resistant to commonly used anti-CMV drugs. About cytomegalovirus CMV is a member of the herpes virus group, which includes the ...ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE, and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. diff . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis
... and the ACR Pedi 70 response was reached by 48% and 73% respectively. Four patients (12%) developed mild adverse events: including one case of cytomegalovirus infection and three varicella zoster virus (VZV) infections. One patient experienced a serious adverse event and was hospitalised for a necrotising ...ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...
ViroPharma to Present at Two May Healthcare Conferences
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide
... patients. Charles Cobbs, M.D., California Pacific Medical Center, is testing the novel hypothesis that infection of cancer stem cells by human cytomegalovirus (HCMV) leads to the development of brain cancer. If true, currently available antiviral drugs or vaccines might be effective in the prevention and ...First evidence for DNA-based vaccination against chronic hepatitis C
... study, researchers developed a T cell vaccine based on a codon-optimised HCV non-structural (NS) 3/4A DNA-gene expressed under the control of the cytomegalovirus immediate-early promoter (ChronVac-C) delivered by in vivo electroporation (EP). A first phase I/IIa clinical trial in HCV infected patients is ...ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...ViroPharma to Host Investor 'Teach-In' Educational Symposium on Hereditary Angioedema
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...Genetic evidence points to potential therapeutic bypass for autoimmune process
... Carma1 gene, which they named the king mutation. The researchers took the Carma1-deficient mice and infected them with a mouse variant of human cytomegalovirus which is related to herpes and chickenpox viruses and can remain dormant or cause serious illness in people with compromised immune systems. ...CMV Infection in Solid Organ Transplantation: Clinical Clues and Prevention Strategies
... A Complimentary Continuing Medical Education Newsletter for Healthcare Professionals VOORHEES, N.J., Feb. 27 /PRNewswire/ -- cytomegalovirus (CMV) infection is an important cause of morbidity and mortality and is the most common viral opportunistic infection in recipients of solid organ ...OHSU vaccine research targets HIV in the slower, early stage of infection
... used a monkey model of AIDS - simian immunodeficiency virus (SIV) the monkey counterpart to HIV. They introduced an altered monkey form of cytomegalovirus (CMV) programmed to express SIV proteins and trigger specialized effector memory T-cells to look for and attack SIV in its early stages. In total, ...... extended preventative therapy ('prophylaxis') with Valcyte met its primary endpoint of reducing the number of kidney transplant patients who develop cytomegalovirus (CMV) disease within the first year post-transplant. Valcyte is indicated for the prevention of CMV disease in kidney, heart, and ...
ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...Poor people suffer disproportionately from chronic infections
... looked at H. Pylori, a bacterium that causes peptic ulcer disease; hepatitis A and B, which can cause liver disease; and herpes simplex 1 and cytomegalovirus (CMV), both implicated in cardiovascular disease, Alzheimer's disease and other ailments. Similarly, there is a large difference in the ...ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile. ViroPharma routinely posts information, including press releases, which may be important to investors in the ...ViroPharma Provides Update on Vancocin(R)
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion
... A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals VOORHEES, N.J., Dec. 15 /PRNewswire/ -- cytomegalovirus (CMV) infection is a serious condition and an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) ...... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile. ViroPharma routinely posts information, including press releases, which may be important to investors in the ...
ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
... the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile . ViroPharma routinely posts information, including press releases, which may be important to investors in the ...... methods of treating a broad spectrum of viral infections, including human immunodeficiency virus (HIV), influenza, hepatitis C virus (HCV) and cytomegalovirus (CMV), using one or more anti-phospholipid antibodies that directly bind to an aminophospholipid target, either alone or in combination with other ...
... program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections. "Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new ...
Vical Announces Strategic Restructuring and Staff Reduction
... its Allovectin- 7(R) immunotherapeutic currently in a pivotal Phase 3 trial in patients with advanced metastatic melanoma, and its DNA vaccine for cytomegalovirus (CMV), currently in a Phase 2 trial in stem cell transplant recipients. The company is exploring partnering opportunities for the congenital disease ...ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
... package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile. ViroPharma routinely posts information, including press releases, which may be important to investors in the investor ...ASP announces 2008 T. Franklin Williams Scholars
... Hopkins University School of Medicine Immunology Dysregulations and Inflammation in the Pathogenesis of Frailty of Older Age: The Role of Chronic cytomegalovirus Infection ASP-American Geriatrics Society Foundation for Health in Aging Award ...ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
... insert at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in infectious diseases including cytomegalovirus (CMV) and C. difficile. For more information on ViroPharma, visit the company's website at http://www.viropharma.com . ...Virus mimics human protein to hijack cell division machinery
... MADISON - Viruses are masters of deception, duping their host's cells into helping them grow and spread. A new study has found that human cytomegalovirus (HCMV) can mimic a common regulatory protein to hijack normal cell growth machinery, disrupting a cell's primary anti-cancer mechanism. Writing in ...ViroPharma Incorporated Reports First Quarter 2008 Financial Results
... insert at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in infectious diseases including cytomegalovirus (CMV) and non-toxigenic C. difficile (NTCD). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com . ...ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
... insert at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com . Disclosure Notice ...Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
... insert at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com . ...ViroPharma Augments Senior Management
... at http://www.viropharma.com/docs/Vancocin_pi_2007.htm ). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com . ...Other Contentsgallbladdergallbladdergallbladdergallgallgallgallgallstonesgallstonesgallstonegallstoneglobulinglobulinglobulingammagammagammagammagammagammagammagammagammagasolinegasolinegasolinegasoline
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 1Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 3Cardiome Pharma Corp Announces Commencement of US 2427 5 Million Tender Offer 55935 1Cardiome Pharma Corp Announces Commencement of US 2427 5 Million Tender Offer 55935 2Cardiome Pharma Corp Announces Commencement of US 2427 5 Million Tender Offer 55935 3Cardiome Pharma Corp Announces Commencement of US 2427 5 Million Tender Offer 55935 4Cardiome Pharma Corp Announces Commencement of US 2427 5 Million Tender Offer 55935 5Jedi Mind Medical Applications Division to Concentrate on Wheelchair Mobility Applications 55932 1Jedi Mind Medical Applications Division to Concentrate on Wheelchair Mobility Applications 55932 2
Breaking Medicine News(10 mins):Health News:Don't I know you? University of Toronto research sheds light on memorial retrieval 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 3Health News:Health Reform is About You and Me, Not One or the Other 2Health News:Health Reform is About You and Me, Not One or the Other 3Health News:West Nile virus infection may persist in kidneys years after initial infection 2Health News:West Nile virus infection may persist in kidneys years after initial infection 3
Other TagsCastroviejoImpairedDraftSwans[0] Nearly 3 Million Doses of H1N1 Vaccine Allocated to Pennsylvania since Start of Vaccination Effort[1] Don't I know you? University of Toronto research sheds light on memorial retrieval[1] Docs Not Giving Clear Advice on Infant Sleep Positions[1] Health Reform is About You and Me, Not One or the Other[0] West Nile virus infection may persist in kidneys years after initial infection
CastroviejoCrossailInabilityPharaohImpairedRobbieJacquelineRosehipsDraftMaxygenChavezElderberrySwansLuciano
Other Tagstan 2option 2option 3option 4option 5option 6option 7option 8option 9option 10exercising 2exercising 3exercising 4exercising 5exercising 6combine 2combine 3combine 4combine 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |